South West Florida

Resilience System


You are here

Home › U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak › U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak

U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak

Primary tabs

U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak

Tue, 2022-10-18 18:38 — mike kraft
U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak The United States sent Gilead Sciences' remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda last week to help safeguard healthcare workers responding to an outbreak that has infected 60 people and killed 44, U.S. government sources told Reuters. Julie Steenhuysen Reuters
...

 

There are currently no proven vaccines or treatments for the Sudan species of Ebola, one of four known Ebola viruses to cause hemorrhagic fever in humans. The outbreak confirmed by the Ugandan health ministry on Sept. 20 is the largest of the Sudan species since 2000.

...

Country / Region Tags: 
Africa
Global
United States
General Topic Tags: 
Disease
Disease Prevention
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.421 seconds.